Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by reducing withdrawal symptoms and cravings associated with nicotine dependence.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine delivered via Nicorette Invisipatch is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: assists adult smokers in managing cravings and withdrawal during quit attempts. - Tobacco dependence: provides a controlled nicotine dose to reduce reliance on cigarettes. - Nicotine withdrawal management: alleviates symptoms such as irritability, anxiety, and difficulty concentrating.

Nicorette Invisipatch may cause a range of adverse reactions. Monitoring and reporting are advised.

Common Side Effects: - Skin irritation at the application site - Itching or redness where the patch is applied - Mild headache - Nausea or stomach discomfort - Dizziness - Sleep disturbances

Serious or Rare Side Effects: - Severe allergic reaction (e.g., rash, swelling, difficulty breathing) - Significant skin blistering or ulceration - Chest pain or palpitations - Uncontrolled hypertension - Persistent vomiting

When using Nicorette Invisipatch, consider the following safety measures.

- Assess nicotine dependence: determine appropriate patch strength under medical guidance. - Contraindications: avoid if known allergy to nicotine or patch components. - Avoid concurrent nicotine products: do not use other NRTs simultaneously. - Cardiovascular monitoring: patients with heart disease should consult a clinician. - Pregnancy and breastfeeding: discuss risks with a healthcare professional before use. - Store at room temperature: keep in original packaging, protect from moisture and direct heat.

Nicotine patches can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause hypertensive episodes. - Use with other nicotine replacement products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., certain antiretrovirals): may increase nicotine plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Certain antidepressants: may alter nicotine metabolism and affect efficacy.